Cognition Therapeutics Inc (NASDAQ: CGTX) started the day on Thursday, with a price decrease of -10.47% at $1.54, before settling in for the price of $1.72 at the close. Taking a more long-term approach, CGTX posted a 52-week range of $0.22-$3.83.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -16.44%. Meanwhile, its Annual Earning per share during the time was -16.44%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 52.91%. This publicly-traded company’s shares outstanding now amounts to $88.27 million, simultaneously with a float of $80.12 million. The organization now has a market capitalization sitting at $135.94 million. At the time of writing, stock’s 50-day Moving Average stood at $1.7154, while the 200-day Moving Average is $0.9208.
Cognition Therapeutics Inc (CGTX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Cognition Therapeutics Inc’s current insider ownership accounts for 9.24%, in contrast to 13.08% institutional ownership. According to the most recent insider trade that took place on Jan 31 ’25, this organization’s CEO & President bought 38,851 shares at the rate of 0.77, making the entire transaction reach 30,001 in total value, affecting insider ownership by 38,851.
Cognition Therapeutics Inc (CGTX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year. Cognition Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 52.91% and is forecasted to reach -0.30 in the upcoming year.
Cognition Therapeutics Inc (NASDAQ: CGTX) Trading Performance Indicators
Let’s observe the current performance indicators for Cognition Therapeutics Inc (CGTX). It’s Quick Ratio in the last reported quarter now stands at 6.44.
In the same vein, CGTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.47, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.30 at the market close of one year from today.
Technical Analysis of Cognition Therapeutics Inc (CGTX)
If we take a close look at the recent performances of Cognition Therapeutics Inc (NASDAQ: CGTX), its last 5-days Average volume was 1.0 million that shows plunge from its year to date volume of 4.33 million. During the previous 9 days, stock’s Stochastic %D was recorded 45.41% While, its Average True Range was 38.84.
Raw Stochastic average of Cognition Therapeutics Inc (CGTX) in the period of the previous 100 days is set at 35.25%, which indicates a major rise in contrast to 3.33% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.1371 that was lower than 0.1903 volatility it exhibited in the past 100-days period.
